Abstract
Background
BRCA1/2 testing is not recommended for children, as risk reduction measures and screening are not generally recommended before 25 years old (YO). Little is known about the prevalence and predictors of parent communication to offspring and how offspring respond to this communication.
Methods
Semi-structured interviews were conducted with parents who had BRCA1/2 testing and at least one child <25 YO. Logistic regressions were utilized to evaluate associations with communication. Framework analysis was utilized to analyze open-ended responses.
Results
253 parents completed interviews (61% response rate), reporting on 505 offspring. 29% of parents were BRCA1/2 mutation carriers. 334 (66%) offspring learned of their parent’s test result. Older offspring age (p<=0.01), offspring gender (female, p=0.05), parents’ negative test result (p=0.03) and parents’ education (high-school only, p=0.02) were associated with communication to offspring. The most frequently reported initial offspring responses were neutral (41%) or relief (28%). 13% of offspring were reported to experience concern or distress (11%) in response to parental communication of their test results. Distress was more frequently perceived among offspring learning of their parent’s BRCA1/2 positive or variant of uncertain significance result.
Conclusion
Many parents communicate their BRCA1/2 test results to young offspring. Parents’ perceptions of offspring responses appear to vary by offspring age and parent test result. A better understanding of how young offspring respond to information about hereditary risk for adult cancer could provide opportunities to optimize adaptive psychosocial responses to risk information and performance of health behaviors, in adolescence and throughout an at-risk lifespan.
INTRODUCTION
In medicine today, there is an increasing expectation that scientific advances in genomics will provide opportunities to inform personalized medical recommendations for the treatment and prevention of disease1-3. BRCA1/2 testing is an example of how genetic testing can be utilized to provide individualized recommendations for disease prevention3-6. Adults with personal or family histories suggestive of hereditary breast and ovarian cancer are candidates for BRCA1/2 testing, which can inform risk reduction measures, such as early increased surveillance, chemoprevention and/or prophylactic surgery7,8. BRCA1/2 mutation carriers are encouraged to inform other adult relatives of the alteration and the opportunity to undergo testing to identify relatives at increased risk. In addition, such testing would identify those who are not at increased risk, and thus, can follow general population screening guidelines7,9.
Prophylactic surgery and radiographic screening for BRCA1/2 mutation carriers are generally not recommended until individuals are 25 years old (YO)7,8. To date, there is no known medical benefit to communicating breast and ovarian cancer risk to offspring under the age of 18 YO9,10, and professional societies have recommended against offering BRCA1/2 testing to children unless there is an immediate medical indication9,11. Yet, debate continues regarding early communication of genetic risk and testing of children for adult-onset genetic disorders12-20. Ethical and clinical arguments have identified potential advantages and disadvantages to early communication of genetic risk to at-risk minor children, although there is no empiric data to support either early communication of genetic risk to at-risk offspring or withholding such information until adulthood21.
There is evidence that many parents do share their genetic test results and the familial risk for cancer with minor at-risk children22-27. This is perhaps not surprising given that parents are encouraged to, and do inform children of their parent’s cancer diagnosis28-32. Several studies have suggested that adolescents are aware of and concerned about their own risk for cancer33-37. Parents have reported disclosure of their BRCA1/2 mutation to children as young as 7 YO, and studies suggest that the majority of late adolescent and young adult offspring learn of the risk in the family23-25.
Few studies have directly evaluated offspring understanding and psychosocial responses to early communication of familial risk25,35,36. Interviews with a small cohort of adult offspring of BRCA1/2 mutation carriers, many of whom learned of their parents BRCA1/2 mutation during adolescence, suggests that many offspring appear to understand the risk communicated by their parent36. Similar to parent reports25, some offspring reported negative reactions to parental communication of familial risk, although many reported that they were not surprised by the information and did not find it distressing36. Additionally, many offspring reported changing their health behaviors in response to parental communication of the familial risk36.
To further explore communication to minor and young adult offspring among parents at risk for hereditary breast cancer, we have been expanding a cohort of parents who received BRCA1/2 testing and had at least one child under 25 YO at the time of testing. We hypothesized that parents who had a negative test result and those with older children would be more likely to share their genetic test results. Based on limited data in a cohort of BRCA1/2 mutation carriers25,36, we further hypothesized that parent reports of offspring reactions might also vary by parent test result, and offspring age and gender.
MATERIALS AND METHODS
Participants
Institutional Review Board approval was obtained before initiating this study. Participants were recruited through the University of Chicago Cancer Risk Clinic and the Fox Chase Cancer Center Risk Assessment Program between February 2004 and July 2009. Eligible participants included those who had undergone BRCA1/2 genetic testing and had one or more offspring under age 25 at the time they received their genetic test result. All participants underwent pre-test and post-test genetic counseling. Informed consent was obtained by research staff prior to conducting telephone interviews.
Survey Instrument
A 31-item semi-structured interview was developed by the investigators to evaluate parent communication of BRCA1/2 test results to offspring and opinions regarding the genetic testing of minors25,38. The interview employed structured (yes/no) and open-ended questions to assess parental disclosure for each eligible child (yes/no), timing of disclosure (open-ended) and parent perceptions of offspring’s initial reaction to the disclosed information (open-ended).
Statistical Analyses
Framework analysis was utilized to analyze open-ended responses39-43. Investigators first intensively reviewed participant responses for a subsample (20%) of participants and developed a thematic framework for each open-ended item. Next, two investigators (AB, LPM) independently assigned thematic codes to the subsample’s open-ended responses regarding parents’ perceptions of offspring reactions to communication of parents’ BRCA1/2 test results (inter-coder agreement 98%). The thematic framework was then applied to the remaining sample and refined to include new themes as they emerged. Responses could be coded for more than one theme. Differences in code assignments were resolved through inter-coder discussion, which established agreement for all responses. Descriptive statistics were utilized to generate response proportions to close-ended items and coded data.
To investigate differences in disclosure to offspring by offspring age and parent test result, we used logistic regressions of disclosure fit by Generalized Estimating Equations (GEE) to account for within parent correlation of responses among children44. Similarly, we used multiple logistic regressions fit by GEE to evaluate the multivariable associations among biomedical factors and demographic factors and disclosure to offspring.
RESULTS
Participant characteristics
Four hundred eighteen eligible parents were contacted to participate and 253 (61%) completed the telephone interview. Forty-nine individuals actively declined participation and 116 failed to participate after multiple contact attempts. Parent and offspring characteristics are described in Table 1. The 253 participants are from 232 unrelated families. The median time from parent receipt of genetic test result to interview was 21 months. Seventy-five percent of parents had received results within 3 years. At the time of parent genetic testing, participants had a total of 505 offspring under 25 YO.
Table 1.
Participant and offspring characteristics
| No. (%) | |
|---|---|
| Parent characteristics (n=253) | |
| Age, years | |
| Mean (SD) | 47.7 (6.8) |
| Median (range) | 48 (28-66) |
| Gender | |
| Women | 241 (95) |
| Men | 12 (5) |
| Parent test result | |
| True positive | 73 (29) |
| True negative | 14 (6) |
| Uninformative negative | 143 (57) |
| VUS | 23 (9) |
| Race/Ethnicity | |
| White | 232 (92) |
| Black | 13 (5) |
| Other | 8 (3) |
| Marital status | |
| Married | 218 (86) |
| Education | |
| High-school or less | 24 (9) |
| Some college | 51 (20) |
| College degree | 86 (34) |
| Graduate education | 92 (36) |
| Personal history of cancer*** | |
| Yes | 169 (67) |
| No | 84 (33) |
| History of prophylactic surgery among female parents (n= 241) | |
| Mastectomy | 52 |
| Oophorectomy | 90 |
| Risk assessment program | |
| University of Chicago | 163 (64) |
| Fox Chase Cancer Center | 90 (36) |
| Mean number relatives with cancer*(SD) | 2.0 (1.5) |
| Median (range) | 2.0 (0-8) |
| Mean earliest cancer in the family** (SD) | 42.4 (8.9) |
| Median (range) | 41.0 (24-78) |
| Offspring Characteristics (n=505) | |
| Age at parent interview, median (range) | 17 (3-35 YO) |
| Less than 10 years old | 81 (16) |
| 10-13 years old | 88 (17) |
| 14-17 years old | 93 (18) |
| 18 and older | 243 (48) |
| Age at parent testing, median (range) | 15 (<1 – 25 YO) |
| Less than 10 years old | 133 (26%) |
| 10-13 years old | 92 (18%) |
| 14-17 years old | 96 (19%) |
| 18-25 years old | 184 (36%) |
| Gender | |
| Female | 253(50) |
| Male | 252(50) |
| Parent test result | |
| True positive | 155 (29) |
| True negative | 29 (6) |
| Uninformative negative | 278 (57) |
| VUS | 43 (9) |
Breast and/or ovarian cancer
Including proband, first-degree and second-degree relatives
Any cancer excluding non-melanoma skin cancer
Rates of parental disclosure of BRCA1/2 test results to offspring
Among 505 offspring, 334 (66%) were reported by parents to have learned of their parent’s test result. Although the majority of parents (84%) reported sharing this information within 1 month of learning their result, 39 (12%) delayed sharing results with offspring (range 1mo – 6 years). The median age at disclosure of offspring who learned of their parent’s test result within 1 month of parent disclosure was 18 YO, compared to offspring disclosed to 1 -12 months (13 YO), or > 12 months (14 YO) after parent disclosure (p=0.006). Sixty-two percent of offspring of parents with a negative result were reported to have been disclosed to within 1 month, while only 41% of offspring of positive parents were disclosed to within 1 month (p<0.001). There was no statistically significant difference in communication delay by offspring gender.
Disclosure rates by offspring age are described in Table 2. Offspring event age (offspring age when their parent disclosed parent’s test results to offspring, or if parent did not disclose their test result to offspring, the age of child at study interview), was used to best characterize offspring age at the time offspring learned of their parent’s BRCA1/2 test result25. The majority of offspring over 14 YO, and approximately half of children 10-13 YO, learned of their parents BRCA1/2 test result. Mean offspring age at parental disclosure of test results was 17.04 YO (SD 4.80, range 4-25 YO).
Table 2.
Disclosure rates among offspring according to offspring age (n= 505)
| Offspring Age | Disclosure by offspring age at interview No. disclosed/offspring (%) | Disclosure by offspring event age* No. disclosed/offspring (%) |
|---|---|---|
| Under 10 years old | 8/81 (10%) | 24/97 (25%) |
| 10-13 years old | 40/88 (45%) | 59/108 (55%) |
| 14-17 years old | 62/93 (67%) | 78/108 (72%) |
| 18-25 years old | 224/243 (92%) | 173/192 (90%) |
Offspring event age = age at disclosure if disclosure occurred or at interview if no disclosure occurred
Predictors of parental disclosure of BRCA1/2 test results to offspring
Prevalence of reported parental disclosure of BRCA1/2 test results to offspring varied significantly by parent test result (Fig 1a) and offspring event age (age of offspring at disclosure or age of offspring at interview if no disclosure occurred) (Fig 1b). Given the relatively smaller number of offspring of parents with a true negative result (TN, i.e. negative for a known BRCA1/2 mutation in the family) or variant of uncertain significance (VUS), all negative results were combined for multivariable analyses. In a single multivariable model, older offspring event age (p<=0.01), female offspring gender (p=0.05), parents’ negative test result (p=0.03) and parents’ lesser education (high-school only, p=0.02) were significantly associated with communication of genetic test results to offspring (Table 3). We ran separate multivariable models to evaluate factors associated with disclosure by parent test result. Offspring event age remained significantly associated with parental disclosure to offspring (p < .01). Female offspring gender was significantly associated with disclosure among offspring of parents with negative test results (p=0.05) and not among offspring of parents with a positive BRCA1/2 test result.
Fig 1.


a. Parent disclosure of BRCA1/2 test results by parent test result (n=505 offspring)
*p-value=0.015 for hypothesis test of general difference in disclosure rates among genetic test result groups using Wald test from GEE-fit logistic regression.
TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation
b. Parental disclosure of BRCA1/2 test results by offspring event age* (n=505 offspring)
*offspring age when their parent disclosed parent’s test results to offspring, or if parent did not disclose their test result to offspring, the age of child at study interview
**p-value<0.001 for hypothesis test of general difference in disclosure rates among age groups using Wald test from GEE-fit logistic regression.
Table 3.
Associations between parent/offspring characteristics and disclosure by multivariable models (n = 492 children**)
| ALL participants (n=492) | BRCA1/2 positive (n=155) | BRCA1/2 negative (n=337) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
| Child event age* | |||||||||
| <10 | - | - | - | - | - | - | - | - | - |
| 10-13 | 2.8 | 1.7-4.6 | <0.01 | 2.7 | 1.0-7.1 | 0.05 | 3.1 | 1.6-5.9 | <0.01 |
| 14-17 | 5.0 | 2.8-8.9 | <0.01 | 4.7 | 1.6-13.7 | 0.01 | 5.1 | 2.5-10.6 | <0.01 |
| 18-24 | 20.9 | 10.2-42.8 | <0.01 | 25.4 | 6.8-95.2 | <0.01 | 19.0 | 7.6-47.5 | <0.01 |
| Parent test result | |||||||||
| Negative | 2.4 | 1.1-5.4 | 0.03 | - | - | - | - | - | |
| - | |||||||||
| Parent gender | |||||||||
| Mother | 3.9 | 0.9-18.1 | 0.08 | 1.9 | 0.2-16.6 | 0.55 | 6.6 | 0.6-71.3 | 0.12 |
| Offspring gender | |||||||||
| Daughter | 1.5 | 1.0-2.2 | 0.05 | 1.3 | 0.6-2.6 | 0.51 | 1.7 | 1.0-2.8 | 0.05 |
| Parent education level | |||||||||
| HS only | 4.8 | 1.3-17.2 | 0.02 | 4.5 | 0.9-22.5 | 0.07 | 6.3 | 0.5-80.0 | 0.16 |
| Parent race | |||||||||
| White | 2.1 | 0.7-5.3 | 0.14 | 0.6 | 0.1-5.8 | 0.68 | 2.9 | 1.0-8.8 | 0.06 |
| Parent cancer history | |||||||||
| Had cancer | 1.4 | 0.7-2.8 | 0.36 | 1.1 | 0.3-3.7 | 0.84 | 1.9 | 0.8-4.6 | 0.18 |
| History of prophylactic mastectomy (females only) | |||||||||
| Yes | 1.4 | 0.7-2.9 | 0.37 | 2.7 | 0.8-8.9 | 0.11 | 0.9 | 0.3-2.4 | 0.82 |
| History of prophylactic oophorectomy (females only) | |||||||||
| Yes | 1.3 | 0.6-2.8 | 0.48 | 1.3 | 0.3-5.3 | 0.75 | 1.2 | 0.5-3.2 | 0.68 |
| No. relatives with cancer | |||||||||
| 1.0 | 0.8-1.2 | 0.95 | 0.8 | 0.5-1.1 | 0.16 | 1.2 | 0.9-1.6 | 0.18 | |
| Age earliest cancer in the family | |||||||||
| 1.0 | 1.0-1.1 | 0.11 | 1.0 | 1.0-1.1 | 0.41 | 1.0 | 1.0-1.1 | 0.20 | |
HS = high school
OR = odds ratio
Event age = offspring age when their parent disclosed parent’s test results to offspring, or if parent did not disclose their test result to offspring, the age of child at study interview
13 offspring excluded for incomplete data (11 missing youngest age of cancer in the family and 2 missing total FDR/SDR with cancer)
Parent perceptions of their children’s reactions to learning their of their parent’s BRCA1/2 test results
Parents who reported disclosure to offspring (n=182 parents) were asked to describe their perceptions of their offspring’s initial response to learning of their parent’s BRCA1/2 test result. The most frequently described offspring responses were neutral (41%), and/or happiness or relief (28%) (Table 4). Examples of neutral responses include: “They just took in the information and had no comments” (17 YO and 20 YO daughters of a mother with a BRCA1/2 mutation) and “they had no real reaction” (10 YO and 12 YO sons of mother with an uninformative negative result). Some parents reported offspring concern (13% of offspring) after sharing their BRCA1/2 test results, including concern for parents (n=24), themselves (n=15), in general (n=9), and other family members (n=1). “She just wanted to know if mommy is going to be ok” (16 YO daughter of mother with an uninformative negative result), and “she was concerned, and hopeful that she doesn’t have the mutation” (15 YO daughter of a mother with a BRCA1/2 mutation). By parent report, a small percentage (11%) of offspring expressed distress (upset, scared, avoidant or fatalistic) in response to parental communication. “They were upset and scared. She thinks every ache and pain means she has cancer”.” He doesn’t want to know his genetic risk for cancer” (19 YO daughter 16 YO son of mother with BRCA1/2 mutation), “She was not relieved. She still feels doomed to get breast cancer” (18 YO daughter of a mother with an uninformative negative result). Some parents reported that their offspring appeared to not understand the information (7%), asked questions or were curious (5%), and/or appreciated the information or found it useful (4%).
Table 4.
Parent perceptions of offspring initial reactions to communication of parent BRCA1/2 test results* (n= 328 offspring)
| Coded response* | All n = 328 | Parent positive n = 84 | Parent Negative n = 244 |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Neutral | 136 (41) | 25 (30) | 111 (44) |
| Relief, happiness | 91 (28) | 0 (0) | 91 (37) |
| Concern | 43 (13) | 28 (33) | 15 (6) |
| Upset, scared, avoidant or fatalistic | 37 (11) | 18 (21) | 19 (8) |
| Didn’t understand | 24 (7) | 12 (14) | 12 (5) |
| Had questions | 16 (5) | 2 (2) | 14 (6) |
| Found information useful | 15 (5) | 5 (6) | 10 (4) |
Responses could be coded for more than one theme. Responses reported at frequencies < 5 not reported.
We conducted separate exploratory analyses to evaluate parents’ perceptions of offspring responses by parent test result, offspring age, and offspring gender. Perceived offspring reactions varied by parent test result (Fig 2a). As might be expected, reports of relief were exclusively reported among offspring not learning of a positive result. Reports of concern among offspring were most frequently reported for offspring learning of a parent’s positive test result (Fig 2a). Parental perceptions of distress (upset, scared, avoidant or fatalistic) among offspring were more frequently reported for offspring learning of their parent’s positive result or VUS. Perceived offspring responses also varied by offspring age at disclosure (Fig 2b). Reports of offspring distress (upset, scared, avoidant or fatalistic), not understanding, and asking questions were more frequently reported for younger offspring (<10 YO). Parents most frequently reported offspring concern in older offspring (14-24 YO). Neutral responses and asking questions were more frequently reported of sons. While parents more frequently described distress among daughters, they also more frequently reported that daughters found the information useful compared to sons (Fig 2c).
Figure 2.



A. Perceived offspring responses by parent test result
TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation
B. Perceived offspring responses by offspring age at disclosure
C. Perceived offspring responses by offspring gender
DISCUSSION
One of the primary motivations for BRCA1/2 testing for parents is to better understand the risk for their offspring45, and studies have shown that many parents do communicate their BRCA1/2 test results to offspring22-25,27. In this study, the largest study to date, the majority of parents reported telling their offspring older than 10 YO of their genetic test result. While prior studies have suggested that most late adolescent and young adult offspring learn of familial and genetic risk for breast and ovarian cancer, our study suggests that many offspring, even younger than 13 YO, also learn of their parent’s BRCA1/2 test results., Other studies have suggested no significant difference in disclosure rates among young (<13 YO) and late adolescents (14-17 YO)22 or late adolescents and young adults (18-25 YO)24. Our study, which focused specifically on communication to children and young adult offspring, identifies disclosure rates that are significantly greater with increasing age, suggesting that age, or parental perception of a correlate of chronological age, such as physical development or psychosocial maturation, are contributors to parent decisions to share their BRCA1/2 test results with offspring. As suggested by others26., and consistent with developmentalists’ recommendations for parent communication of a cancer diagnosis46, parents might feel more confident that an older child can understand and benefit from the genetic test results. Additionally, offspring exposure to, and knowledge of, genetics as offspring mature might prompt offspring questions and discussion of the parent’s genetic test results.
Although prior studies have not shown a significant difference in disclosure among parents with a positive or negative test result22-24, we found that offspring are more likely to learn of a parent’s negative than positive test result and daughters are more likely to learn of a negative result, independent of child age. This is not surprising given the different medical indications and testing opportunities (when reaching adulthood) for offspring of parents with negative and positive test results. Additionally, it has been hypothesized that parents respond differentially to health related issues by offspring gender only after offspring reach adolescence47. Thus, it is possible that discussion of daughters’ risk becomes incorporated into other parent-daughter conversations surrounding puberty and breast development. While communication was significantly higher from parents to daughters than sons, this difference was significant among parents’ with negative, but not positive BRCA1/2 test results. It has been suggested that girls might be more perceptive of the physical cues of, and more emotionally challenged by puberty48. Thus, parents with negative results might be more likely to share this information with daughters to offer health reassurance during puberty and given the implications of breast cancer for women. Similar to at least one study evaluating maternal communication of a breast cancer diagnosis to offspring, BRCA1/2 mutation carriers with less formal education were more likely to share their BRCA1/2 test results with offspring28. Also similar to other studies22,23, parental diagnosis of cancer in our study was not significantly associated with communication of genetic test results to offspring.
In an earlier study, we found that some parents with a BRCA1/2 mutation reported witnessing distress (26%) or concern (22%) in their offspring after sharing their BRCA1/2 test results with their offspring25. In this larger study evaluating disclosure to 505 offspring and including parents with negative and positive results, parents reported fewer offspring having negative reactions to learning their parent’s genetic test result. Yet, parent reports of offspring responses did appear to vary by parent test result, offspring age and offspring gender, and rates of distress and concern among offspring learning of a parents’ positive BRCA1/2 mutation are consistent with our earlier study. Our data suggests that offspring learning of a parent’s positive or VUS result may be more likely to experience distress or have questions about parents’ result. Our data also suggest age-related differences in offspring responses, with distress more common in offspring under 10 YO, and concern more common in offspring between 14-24 years. More advanced cognitive development in older offspring might allow for more adaptive means of coping. As well, their more mature emotional regulation skills might allow them to appear less distressed than they feel, making it more difficult for parents to accurately gauge their reactions46. We acknowledge that differences in parent reports of offspring response may also reflect parent factors (e.g. cancer specific distress, depression, cancer history)32. Thus, parent report of offspring response might not correlate highly with offspring responses29,47,49-51. Direct evaluation of offspring’s psychosocial response is critical to provide an offspring-centered understanding of the risks and benefits of early parental communication of genetic risk for breast and ovarian cancer. Yet, understanding both parent and offspring perspectives is invaluable in understanding how parents perceive their offspring’s experience in receiving genetic or family risk information, and the resultant implications for developing interventions to facilitate communication of those undergoing genetic testing to offspring and other family members.
Although informative, we acknowledge several limitations to this study. Parents were asked to report on communication events and experiences that occurred retrospectively, which allow for potential recall bias. Our results only describe parents’ general perceptions of offspring reactions, which could not be expected to elucidate all of the parent and offspring factors that mediate and moderate those outcomes. Future longitudinal study, most importantly including interviews with offspring, can better inform the biopsychosocial impact of this communication on offspring psychosocial development, and behavioral and psychosocial adaptation over time47. An additional limitation is that, as with most studies in families at increased risk of breast and ovarian cancer, participants who were recruited from specialized cancer risk clinics were highly educated, and minorities were underrepresented. Thus, these findings might not apply to a more diverse population of BRCA1/2 mutation carriers. It is also possible that participants in this study represent a population more likely to communicate to offspring than non-participants. The number of parents with a true negative result and VUS results were relatively small. It is possible that there are differences in communication among parents with true negative, VUS and uninformative negative results that could not be detected in this cohort. Given the different clinical implications of these results, future research evaluating these differences in a sample with greater representation among these subgroups could be valuable.
In conclusion, many parents report communicating their BRCA1/2 test results to their offspring even at young ages. The clinical impact of this communication remains unknown, however the rate of communication to children and adolescents is high, and the data suggest that a majority of offspring do not find this information distressing. Many health and risk behaviors that impact the morbidity and mortality of youths and adults begin in (e.g. tobacco and alcohol use, and sexual activity) or become established in (e.g. diet and exercise) adolescence 52-54. If done effectively, early communication of hereditary risk provide a “teachable moment”, initiating or establishing risk reductive behaviors36,54. A better understanding of how children, adolescents and young adults respond to and utilize information about hereditary risks for adult cancer, including genetic risk information such as BRCA1/2 status, and how those processes change developmentally into, during and out of adolescence has the potential to provide opportunities to facilitate protective health behaviors in adolescence and throughout the lifespan that have the potential to reduce the morbidity and mortality of BRCA1/2-assocaited and other hereditary cancers throughout the lifespan.
Acknowledgments
Research support: American Cancer Society, Mentored Research Scholar Award (MRSG 07-014-01-CPPB). Support was also provided by NIH grant P30 CA006927.
Footnotes
Conflict of Interest Statement There are no conflicts of interest to disclose.
References
- 1.Khoury MJ, Gwinn M, Yoon PW, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–74. doi: 10.1097/GIM.0b013e31815699d0. [DOI] [PubMed] [Google Scholar]
- 2.Burke W, Psaty BM. Personalized medicine in the era of genomics. Jama. 2007;298:1682–4. doi: 10.1001/jama.298.14.1682. [DOI] [PubMed] [Google Scholar]
- 3.Olopade OI, Grushko TA, Nanda R, et al. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res. 2008;14:7988–99. doi: 10.1158/1078-0432.CCR-08-1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Calzone KA, Soballe PW. Genetic testing for cancer susceptibility. Surg Clin North Am. 2008;88:705–21. doi: 10.1016/j.suc.2008.05.003. v. [DOI] [PubMed] [Google Scholar]
- 5.Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 28:893–901. doi: 10.1200/JCO.2009.27.0660. [DOI] [PubMed] [Google Scholar]
- 6.Schwartz GF, Hughes KS, Lynch HT, et al. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer. 2008;113:2627–37. doi: 10.1002/cncr.23903. [DOI] [PubMed] [Google Scholar]
- 7.Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med. 2007;357:154–62. doi: 10.1056/NEJMcp071286. [DOI] [PubMed] [Google Scholar]
- 8.Daly MB, Axilbund JE, Bryant E, et al. The National Comprehensive Cancer Network Clinical Practive Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast and Ovarian (v.1.2010) 2010 [Google Scholar]
- 9.American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397–406. doi: 10.1200/JCO.2003.03.189. [DOI] [PubMed] [Google Scholar]
- 10.Kodish ED. Testing children for cancer genes: the rule of earliest onset. J Pediatr. 1999;135:390–5. doi: 10.1016/s0022-3476(99)70142-3. [DOI] [PubMed] [Google Scholar]
- 11.Borry P, Stultiens L, Nys H, et al. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet. 2006;70:374–81. doi: 10.1111/j.1399-0004.2006.00692.x. [DOI] [PubMed] [Google Scholar]
- 12.Borry P, Goffin T, Nys H, et al. Predictive genetic testing in minors for adult-onset genetic diseases. Mt Sinai J Med. 2008;75:287–96. doi: 10.1002/msj.20038. [DOI] [PubMed] [Google Scholar]
- 13.Cohen CB. Wrestling with the future: should we test children for adult-onset genetic conditions? Kennedy Inst Ethics J. 1998;8:111–30. doi: 10.1353/ken.1998.0014. [DOI] [PubMed] [Google Scholar]
- 14.Rhodes R. Why test children for adult-onset genetic diseases? Mt Sinai J Med. 2006;73:609–16. [PubMed] [Google Scholar]
- 15.Elger BS, Harding TW. Testing adolescents for a hereditary breast cancer gene (BRCA1): respecting their autonomy is in their best interest. Arch Pediatr Adolesc Med. 2000;154:113–9. doi: 10.1001/archpedi.154.2.113. [DOI] [PubMed] [Google Scholar]
- 16.Robertson S, Savulescu J. Is there a case in favour of predictive genetic testing in young children? Bioethics. 2001;15:26–49. doi: 10.1111/1467-8519.00210. [DOI] [PubMed] [Google Scholar]
- 17.Pelias MK. Genetic testing of children for adult-onset diseases: is testing in the child’s best interests? Mt Sinai J Med. 2006;73:605–8. [PubMed] [Google Scholar]
- 18.Malpas PJ. Predictive genetic testing of children for adult-onset diseases and psychological harm. J Med Ethics. 2008;34:275–8. doi: 10.1136/jme.2006.019802. [DOI] [PubMed] [Google Scholar]
- 19.Clarke A. What is at stake in the predictive genetic testing of children? Fam Cancer. 9:19–22. doi: 10.1007/s10689-009-9260-x. [DOI] [PubMed] [Google Scholar]
- 20.Fenwick A. Are guidelines for genetic testing of children necessary? Fam Cancer. 9:23–5. doi: 10.1007/s10689-009-9278-0. [DOI] [PubMed] [Google Scholar]
- 21.Mackenzie A, Patrick-Miller L, Bradbury AR. Controversies in communication of genetic risk for hereditary breast cancer. Breast J. 2009;15(Suppl 1):S25–32. doi: 10.1111/j.1524-4741.2009.00800.x. [DOI] [PubMed] [Google Scholar]
- 22.Tercyak KP, Hughes C, Main D, et al. Parental communication of BRCA1/2 genetic test results to children. Patient Educ Couns. 2001;42:213–24. doi: 10.1016/s0738-3991(00)00122-1. [DOI] [PubMed] [Google Scholar]
- 23.Tercyak KP, Peshkin BN, DeMarco TA, et al. Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns. 2002;47:145–53. doi: 10.1016/s0738-3991(01)00192-6. [DOI] [PubMed] [Google Scholar]
- 24.Patenaude AF, Dorval M, DiGianni LS, et al. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006;24:700–6. doi: 10.1200/JCO.2005.01.7541. [DOI] [PubMed] [Google Scholar]
- 25.Bradbury AR, Dignam JJ, Ibe CN, et al. How often do BRCA mutation carriers tell their young children of the family’s risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007;25:3705–11. doi: 10.1200/JCO.2006.09.1900. [DOI] [PubMed] [Google Scholar]
- 26.Clarke S, Butler K, Esplen MJ. The phases of disclosing BRCA1/2 genetic information to offspring. Psychooncology. 2008;17:797–803. doi: 10.1002/pon.1344. [DOI] [PubMed] [Google Scholar]
- 27.Hughes C, Lynch H, Durham C, et al. Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Res Ther Cont. 1999;8:51–59. [Google Scholar]
- 28.Barnes J, Kroll L, Lee J, et al. Factors predicting communication about the diagnosis of maternal breast cancer to children. J Psychosom Res. 2002;52:209–14. doi: 10.1016/s0022-3999(02)00296-9. [DOI] [PubMed] [Google Scholar]
- 29.Compas BE, Worsham NL, Epping-Jordan JE, et al. When mom or dad has cancer: markers of psychological distress in cancer patients, spouses, and children. Health Psychol. 1994;13:507–15. [PubMed] [Google Scholar]
- 30.Shands ME, Lewis FM, Zahlis EH. Mother and child interactions about the mother’s breast cancer: an interview study. Oncol Nurs Forum. 2000;27:77–85. [PubMed] [Google Scholar]
- 31.Fitch MI, Abramson T. Information needs of adolescents when a mother is diagnosed with breast cancer. Can Oncol Nurs J. 2007;17:16–25. doi: 10.5737/1181912x1711620. [DOI] [PubMed] [Google Scholar]
- 32.Hoke LA. Psychosocial adjustment in children of mothers with breast cancer. Psychooncology. 2001;10:361–9. doi: 10.1002/pon.515. [DOI] [PubMed] [Google Scholar]
- 33.Cappelli M, Verma S, Korneluk Y, et al. Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clin Genet. 2005;67:481–91. doi: 10.1111/j.1399-0004.2005.00456.x. [DOI] [PubMed] [Google Scholar]
- 34.Geller G, Tambor ES, Bernhardt BA, et al. Mothers and daughters from breast cancer families: a qualitative study of their perceptions of risks and benefits associated with minor’s participation in genetic susceptibility research. J Am Med Womens Assoc. 2000;55:280–4. 293. [PubMed] [Google Scholar]
- 35.Tercyak KP, Peshkin BN, Streisand R, et al. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psychooncology. 2001;10:336–46. doi: 10.1002/pon.531. [DOI] [PubMed] [Google Scholar]
- 36.Bradbury AR, Patrick-Miller L, Pawlowski K, et al. Learning of your parent’s BRCA mutation during adolescence or early adulthood: a study of offspring experiences. Psychooncology. 2009;18:200–8. doi: 10.1002/pon.1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Silk KJ, Bigbsy E, Volkman J, et al. Formative research on adolescent and adult perceptions of risk factors for breast cancer. Soc Sci Med. 2006;63:3124–36. doi: 10.1016/j.socscimed.2006.08.010. [DOI] [PubMed] [Google Scholar]
- 38.Bradbury AR, Patrick-Miller L, Egleston BL, et al. Parent opinions regarding the genetic testing of minors for BRCA1/2. JCO. 2010 Jul 20;28(21):3498–3505. doi: 10.1200/JCO.2009.27.2971. [DOI] [PubMed] [Google Scholar]
- 39.Pope C, van Royen P, Baker R. Qualitative methods in research on healthcare quality. Qual Saf Health Care. 2002;11:148–52. doi: 10.1136/qhc.11.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. In: Bryman A, Burgess R, editors. Analysing Qualitative Data. Routledge; London: 1994. pp. 173–194. [Google Scholar]
- 41.Scott SE, Grunfeld EA, Main J, et al. Patient delay in oral cancer: a qualitative study of patients’ experiences. Psychooncology. 2006;15:474–85. doi: 10.1002/pon.976. [DOI] [PubMed] [Google Scholar]
- 42.Velikova G, Awad N, Coles-Gale R, et al. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology. 2008;17:690–8. doi: 10.1002/pon.1295. [DOI] [PubMed] [Google Scholar]
- 43.Husain LS, Collins K, Reed M, et al. Choices in cancer treatment: a qualitative study of the older women’s (>70 years) perspective. Psychooncology. 2008;17:410–6. doi: 10.1002/pon.1242. [DOI] [PubMed] [Google Scholar]
- 44.Liang KY, Zeger SL. Longitudinal data-analysis using generalized linear models. Biometrika. 1986;73:13–22. [Google Scholar]
- 45.Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Jama. 1996;275:1885–92. [PubMed] [Google Scholar]
- 46.Moore CW, Rauch PK. Addressing parenting concerns of bone marrow transplant patients: opening (and closing) Pandora’s box. Bone Marrow Transplant. 2006;38:775–82. doi: 10.1038/sj.bmt.1705522. [DOI] [PubMed] [Google Scholar]
- 47.Scalzo C, Williams PG, Holmbeck GN. Maternal Self-Assessed Health and Emotionality Predict Maternal Response to Child Illness. Children’s Health Care. 2005;34:61–69. [Google Scholar]
- 48.Salovey P, Birnbaum D. Influence of mood on health-relevant cognitions. J Pers Soc Psychol. 1989;57:539–51. doi: 10.1037//0022-3514.57.3.539. [DOI] [PubMed] [Google Scholar]
- 49.Welch AS, Wadsworth ME, Compas BE. Adjustment of children and adolescents to parental cancer. Parents’ and children’s perspectives. Cancer. 1996;77:1409–18. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1409::AID-CNCR28>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
- 50.Forrest G, Plumb C, Ziebland S, et al. Breast cancer in the family--children’s perceptions of their mother’s cancer and its initial treatment: qualitative study. Bmj. 2006;332:998–1003. doi: 10.1136/bmj.38793.567801.AE. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Armsden GC, Lewis FM. Behavioral adjustment and self-esteem of school-age children of women with breast cancer. Oncol Nurs Forum. 1994;21:39–45. [PubMed] [Google Scholar]
- 52.Cohen RY, Brownell KD, Felix MR. Age and sex differences in health habits and beliefs of schoolchildren. Health Psychol. 1990;9:208–24. doi: 10.1037//0278-6133.9.2.208. [DOI] [PubMed] [Google Scholar]
- 53.Chassin L, Presson CC, Sherman SJ, et al. The natural history of cigarette smoking: predicting young-adult smoking outcomes from adolescent smoking patterns. Health Psychol. 1990;9:701–16. doi: 10.1037//0278-6133.9.6.701. [DOI] [PubMed] [Google Scholar]
- 54.Williams PG, Holmbeck GN, Greenley RN. Adolescent health psychology. J Consult Clin Psychol. 2002;70:828–42. [PubMed] [Google Scholar]
